Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Program
        • PEP++ project
        • PEP4LEP 2.0 & PEP4LEP
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • Prevention of Leprosy (SDR-PEP) Toolkit
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030

World Health Organization . 2021;
Download PDF
Publication

Network Pharmacology‒Guided in Silico Screening and Molecular Dynamics Investigation of Madecassoside for Leprosy

Pushbaraj S, Saravanan V, Muthukumaradoss MM, et al. Wiley. ChemistrySelect. 2026;
Publication

Patient-attributed lunar periodicity in probable ulcerated erythema nodosum leprosum: A case report and proposed psychoneuroendocrine mechanism

Hagos BT, Weldemedhn SG, Geto RG, et al. Elsevier BV. IDCases. 2026;
Download PDF
Publication

Clinical profile of uveitis in leprosy in a cohort of patients in Egypt

Zakaria N, Saleh MGA, Ashour DM, et al. Springer Science and Business Media LLC. International Ophthalmology. 2026;
Practical material

Global leprosy (Hansen Disease) update, 2025: Strengtheninga person-centered approach is integral to elimination of leprosy

World Health Organization. 2026;
Access resource
Publication

Sustaining interruption of leprosy transmission in Eswatini: lessons from years of programme transition

Mbongiseni M, Pandey DK, Zulisile Z, et al. Oxford University Press (OUP). Transactions of The Royal Society of Tropical Medicine and Hygiene. 2026;
Publication

Gendered experiences of people living with tuberculosis or leprosy: A global systematic review

Unterkircher SCW, Lenz J, Mwasuka G, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2026; 20 (9) : 1 - 25.
Download PDF
Publication

Risk factors associated with leprosy in Bongo District, Ghana: a mixed methods study

Adabre IA, Kwabla MP, Appiah SCY, et al. Frontiers Media SA. Frontiers in Tropical Diseases. 2026;
Download PDF
Publication

Leprosy in Sudan: What is the current situation?

Niyle RM, Salium JAA, Eltahir MS, et al. Prof Medical Research Consultancy Center. Medical Research Updates Journal. 2025; 3 (2) : 21 - 30.
Download PDF
Publication

Beyond elimination: Assessing healthcare access, knowledge, attitudes, and practices regarding leprosy among communities in Lilongwe and Balaka districts of Malawi

Singano N, Lubanga A, Kacheyo J, et al. PLoS neglected tropical diseases. 2026; 20 (7) : 1 - 15.
Download PDF

Pagination

  • Page 1
  • Next page ››
Subscribe to African Region (AFR)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD